SS-31: A Practical Guide to Mitochondrial Optimization (Part 3)

SS-31 (also known as elamipretide) is receiving growing attention for its ability to directly support mitochondrial function. By stabilizing the inner mitochondrial membrane, it helps reduce oxidative damage while improving energy production and recovery. The following framework translates clinical and research data into usable dosing tiers for different goals.

TIER 1 – GENERAL LONGEVITY & OPTIMIZATION Healthy adults over 35 focused on aging well and everyday recovery.

• Dose: 1–2 mg daily
• Best for: Healthy adults over 35 seeking general mitochondrial support, improved recovery, and healthy aging
• Timing: Morning preferred
• Cycle: 8–12 weeks on, followed by 4 weeks off

TIER 2 – ATHLETIC PERFORMANCE & RECOVERY Athletes or high-volume trainers seeking better metabolic output and resilience.

• Dose: 3–5 mg daily
• Best for: Athletes with high training volume who want recovery enhancement and metabolic optimization
• Timing: Morning or 60 minutes pre-training
• Cycle: 6–8 weeks on, followed by 4 weeks off

TIER 3 – SIGNIFICANT DYSFUNCTION OR RECOVERY Post-viral recovery, chronic fatigue, advanced metabolic issues, or measurable decline.

• Dose: 5–10 mg daily
• Best for: Post-viral recovery, chronic fatigue, advanced metabolic dysfunction, CKD risk, and older individuals with measurable decline
• Cycle: 4–6 weeks on at the higher dose, then taper to 3–5 mg

10 mg Vial Add 2 mL bacteriostatic water → 5 mg/mL concentration

• 1 mg = 20 units
• 2 mg = 40 units
• 3 mg = 60 units
• 5 mg = 100 units

50 mg Vial (Most Common Research Format) Add 2 mL bacteriostatic water → 25 mg/mL concentration

• 1 mL = 25 mg
• 0.1 mL (10 units) = 2.5 mg
• 0.01 mL (1 unit) = 0.25 mg

DOSE CONVERSION TABLE – 50 mg VIAL + 2 mL BACTERIOSTATIC WATER

• 1 mg 4 units

2 mg = 8 units 3 mg = units 4 mg = 16 units 5 mg = 20 units 6 mg = 24 units 7 mg = 28 units 8 mg = 32 units 9 mg = 36 units 10 mg = 40 units 15 mg = 60 units 20 mg = 80 units 25 mg = 100 units

Reconstitution Rules Inject water slowly down the inner glass wall. Never inject directly onto the powder. Never shake the vial. Swirl gently if needed. Maintain sterile technique throughout.

Weeks 1–2: 3 mg/day (12 units) Weeks 3–8: 5 mg/day (20 units) Weeks 9–12: Remain at 5 mg/day if recovery, HRV, sleep, and training metrics continue to improve

Vial Usage Estimates at 5 mg/day - One 50 mg vial lasts 10 days. A full 12-week protocol requires approximately 9 vials (450 mg total).

Vial Usage Estimates at 3 mg/day - One 50 mg vial lasts 16–17 days. An 8-week protocol requires approximately 4 vials (168 mg total).

At 5 mg/day, meaningful improvements in recovery, resilience, and mitochondrial efficiency are more likely to be noticed than at the lower 1–2 mg range.

• Standard Optimization Cycle: 8 weeks on, 4 weeks off
• Aggressive Optimization Cycle: 12 weeks on, 4 weeks off
• Continuous Low-Dose Protocol: 1–2 mg daily, potentially indefinitely (supported by long-term safety data)
• Acute Recovery Cycle: 4–6 weeks, suitable for surgery recovery, illness recovery, or competition preparation

Mitochondrial Trifecta

• SS-31 – repairs mitochondrial infrastructure
• MOTS-c – improves mitochondrial signaling
• Humanin – enhances cellular survival pathways

Suggested Progression

• Weeks 1–8: SS-31 alone
• Weeks 9–12: Add MOTS-c
• Week 12+: Evaluate maintenance strategy

Synergistic Combinations

• SS-31 + MOTS-c – the most logical mitochondrial stack available
• SS-31 + HGH / Tesamorelin – mitochondrial efficiency plus tissue remodeling
• SS-31 + GLP-1 Agonists – supports muscle mitochondria during caloric restriction
• SS-31 + NAD+ – repairs structure while supporting substrate availability
• SS-31 + BPC-157 / TB-500 – useful during injury rehabilitation

Baseline and again at Week 8–12

Metabolic Panel Fasting insulin, HbA1c, CMP, lipid panel, ApoB

Inflammatory Markers hsCRP, ferritin

Hormonal Panel TSH, Free T4, Free T3

Performance Metrics HRV, VO₂ Max, resting heart rate, grip strength, sleep quality, recovery metrics

Additional Renal and Cardiovascular Markers (Recommended for This Profile) Cystatin-C, creatinine, eGFR, urine albumin/creatinine ratio

SS-31 has demonstrated one of the strongest safety records among mitochondrial-targeted compounds. Across long-term studies, no significant serious drug-related adverse events have been reported. Mild injection-site reactions remain the most common observation. Long-term exposure exceeding 168 weeks has been documented with no cumulative toxicity signal.

Common Side Effects Mild redness, itching, injection-site swelling, temporary headaches

Contradications Avoid or discuss carefully with a physician if pregnant, breastfeeding, active malignancy, or severe acute medical instability.

Current protocol includes TRT, HGH, MOTS-c, NAD+, Jardiance, Telmisartan, Ezetimibe, high training volume, and focused goals around longevity and body composition. In this context, SS-31 functions best as a foundational mitochondrial support compound rather than a top-level performance enhancer.

Recommended Protocol for this profile

• SS-31: 3–5 mg daily
• MOTS-c: 4–8 mg three times weekly
• NAD+: training days
• HGH: continue current protocol
• Jardiance: continue as prescribed
• Training: daily resistance training + Zone 2 cardio for optimized fat loss

Duration: 8–12 week block followed by reassessment of recovery, HRV, body composition, renal biomarkers, and training performance.

Expected Outcomes For someone already highly optimized, the realistic benefits are not dramatic increases in energy but rather:

• Improved recovery capacity
• Improved mitochondrial efficiency
• Better training resilience
• Improved renal and cardiovascular protection
• Reduced cumulative oxidative stress
• Better preservation of performance with age

SS-31’s core value lies in supporting the mitochondrial infrastructure upon which every other performance and longevity intervention ultimately depends.